Akebia Therapeutics
AKBA
AKBA
153 hedge funds and large institutions have $412M invested in Akebia Therapeutics in 2018 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 49 increasing their positions, 37 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
16% more funds holding
Funds holding: 132 → 153 (+21)
6.08% more ownership
Funds ownership: 71.29% → 77.36% (+6.1%)
12% less capital invested
Capital invested by funds: $470M → $412M (-$58.5M)
Holders
153
Holding in Top 10
3
Calls
$3.24M
Puts
$224K
Top Buyers
| 1 | +$13.8M | |
| 2 | +$13.6M | |
| 3 | +$9.17M | |
| 4 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$8.34M |
| 5 |
Renaissance Technologies
New York
|
+$6.65M |
Top Sellers
| 1 | -$12.3M | |
| 2 | -$3.49M | |
| 3 | -$3.09M | |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$2.68M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$2.38M |